Välimäki MJ - Search Results

1

Genetically defined adult-type hypolactasia and self-reported lactose intolerance as risk factors of osteoporosis in Finnish postmenopausal women.

Enattah N, Pekkarinen T, Välimäki MJ, Löyttyniemi E, Järvelä I. Enattah N, et al. Among authors: valimaki mj. Eur J Clin Nutr. 2005 Oct;59(10):1105-11. doi: 10.1038/sj.ejcn.1602219. Eur J Clin Nutr. 2005. PMID: 16015262

2

[Male osteoporosis].

Andersson S, Välimäki M. Andersson S, et al. Duodecim. 2009;125(10):1109-16. Duodecim. 2009. PMID: 19585908 Finnish.

3

[When and how should osteoporosis be treated?].

Välimäki M. Välimäki M. Duodecim. 1993;109(20):1785-92. Duodecim. 1993. PMID: 7737001 Review. Finnish. No abstract available.

4

[Calcitonin in the development and treatment of osteoporosis].

Välimäki M. Välimäki M. Duodecim. 1990;106(12):905-7. Duodecim. 1990. PMID: 1670330 Review. Finnish. No abstract available.

5

Risk factors for reduced areal bone mineral density in young adults with stem cell transplantation in childhood.

Taskinen M, Kananen K, Välimäki M, Löyttyniemi E, Hovi L, Saarinen-Pihkala U, Lipsanen-Nyman M. Taskinen M, et al. Pediatr Transplant. 2006 Feb;10(1):90-7. doi: 10.1111/j.1399-3046.2005.00405.x. Pediatr Transplant. 2006. PMID: 16499594

6

Associations of genetic lactase non-persistence and sex with bone loss in young adulthood.

Laaksonen MM, Impivaara O, Sievänen H, Viikari JS, Lehtimäki TJ, Lamberg-Allardt CJ, Kärkkäinen MU, Välimäki M, Heikkinen J, Kröger LM, Kröger HP, Jurvelin JS, Kähönen MA, Raitakari OT; Cardiovascular Risk in Young Finns Study Group. Laaksonen MM, et al. Bone. 2009 May;44(5):1003-9. doi: 10.1016/j.bone.2008.12.019. Epub 2009 Jan 3. Bone. 2009. PMID: 19168163

7

Effects of hormone therapy and alendronate on C-reactive protein, E-selectin, and sex hormone-binding globulin in osteoporotic women.

Ylikorkala O, Eviö S, Välimäki M, Tiitinen A. Ylikorkala O, et al. Fertil Steril. 2003 Sep;80(3):541-5. doi: 10.1016/s0015-0282(03)00753-2. Fertil Steril. 2003. PMID: 12969695 Clinical Trial.

8

Cardiovascular morbidity and mortality in surgically treated hyperthyroidism - a nation-wide cohort study with a long-term follow-up.

Ryödi E, Salmi J, Jaatinen P, Huhtala H, Saaristo R, Välimäki M, Auvinen A, Metso S. Ryödi E, et al. Clin Endocrinol (Oxf). 2014 May;80(5):743-50. doi: 10.1111/cen.12359. Epub 2013 Dec 5. Clin Endocrinol (Oxf). 2014. PMID: 24304446

9

Cancer Incidence and Mortality in Patients Treated Either With RAI or Thyroidectomy for Hyperthyroidism.

Ryödi E, Metso S, Jaatinen P, Huhtala H, Saaristo R, Välimäki M, Auvinen A. Ryödi E, et al. J Clin Endocrinol Metab. 2015 Oct;100(10):3710-7. doi: 10.1210/jc.2015-1874. Epub 2015 Aug 11. J Clin Endocrinol Metab. 2015. PMID: 26262435

10

The same annual dose of 292000 IU of vitamin D (cholecalciferol) on either daily or four monthly basis for elderly women: 1-year comparative study of the effects on serum 25(OH)D concentrations and renal function.

Pekkarinen T, Välimäki VV, Aarum S, Turpeinen U, Hämäläinen E, Löyttyniemi E, Välimäki MJ. Pekkarinen T, et al. Among authors: valimaki mj, valimaki vv. Clin Endocrinol (Oxf). 2010 Apr;72(4):455-61. doi: 10.1111/j.1365-2265.2009.03637.x. Epub 2009 May 25. Clin Endocrinol (Oxf). 2010. PMID: 19486025 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results